BharatRohan Advances Hyperspectral Imaging to Detect Counterfeit Medicines
BharatRohan Airborne Innovations Limited has reached a key milestone using hyperspectral imaging to identify counterfeit and substandard pharmaceutical tablets by analyzing their spectral signatures without damaging samples. This non-destructive technology, previously applied in agriculture, shows promise for pharmaceutical quality screening and anti-counterfeiting. The company is pursuing scientific and regulatory validation before commercial deployment, aiming to complement existing laboratory testing methods.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (72/100). Lens Score 38/100.
Outlets measured: thetribune, thehindu. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (68–75/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
thehindu broke this story on 12 Nov, 05:40 pm. Other outlets followed.